Evidence map›Paper›PMID 16339739›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2005

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Susan R Weiss, Sonia Navas-Martin

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 648 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
648citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04869579 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients

TypeinterventionalSponsorCHRISTUS HealthRan2021 to 2021Enrolled100ConditionsCovid19ArmsSelenium (as Selenious Acid), Placebo
NCT06597370 completednot on this mapstarted 2021, after this paper: background citation

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population: mRNA Expression for IgG Anti-spike

Typeobservational_patient_registrySponsorNational Polytechnic Institute, MexicoRan2021 to 2021Enrolled80ConditionsCOVID-19 VaccineArmsGene expression mRNA of IgG anti-spike
3 · Its place in the literature

Who cites it

648 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

588 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Susan R WeissDepartment of Microbiology, University of Pennsylvania School of Medicine, 36th Street and Hamilton Walk, Philadelphia, Pennsylvania 19104-6076, USA. weisssr@mail.med.upenn.edu
Sonia Navas-Martin

Funding

PATHOGNESIS OF MOUSE HEPATITIS CORONAVIRUSP01NS030606 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GONZALEZ-SCARANO, FRANCISCO A · 1993 to 2002
$3.2M
Molecular Biology of Coronavirus Induced DemyelinationR01AI060021 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 2003 to 2013
$2.7M
Role of T Cell Epitopes in Coronavirus PathogenesisR01AI047800 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R. · 2002 to 2006
$1.6M
CORONAVIRUSES: MOLECULAR BIOLOGY AND PERSISTENCER01AI017418 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R. · 1985 to 2004
$1.4M
MOLECULAR BIOLOGY OF CORONAVIRUS-INDUCED DEMYELINATIONR01NS021954 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R. · 1985 to 2002
$645k
NIAID NIH HHS AI17418NIAID NIH HHS AI47800NIAID NIH HHS AI60021NIAID NIH HHS N01 AI060021NIAID NIH HHS R01 AI017418NIAID NIH HHS R01 AI047800NINDS NIH HHS NS21954NINDS NIH HHS NS30606NINDS NIH HHS P01 NS030606
6 · The paper itself

Abstract

Coronaviruses are a family of enveloped, single-stranded, positive-strand RNA viruses classified within the Nidovirales order. This coronavirus family consists of pathogens of many animal species and of humans, including the recently isolated severe acute respiratory syndrome coronavirus (SARS-CoV). This review is divided into two main parts; the first concerns the animal coronaviruses and their pathogenesis, with an emphasis on the functions of individual viral genes, and the second discusses the newly described human emerging pathogen, SARS-CoV. The coronavirus part covers (i) a description of a group of coronaviruses and the diseases they cause, including the prototype coronavirus, murine hepatitis virus, which is one of the recognized animal models for multiple sclerosis, as well as viruses of veterinary importance that infect the pig, chicken, and cat and a summary of the human viruses; (ii) a short summary of the replication cycle of coronaviruses in cell culture; (iii) the development and application of reverse genetics systems; and (iv) the roles of individual coronavirus proteins in replication and pathogenesis. The SARS-CoV part covers the pathogenesis of SARS, the developing animal models for infection, and the progress in vaccine development and antiviral therapies. The data gathered on the animal coronaviruses continue to be helpful in understanding SARS-CoV.

Indexed as

AnimalsCatsCattleCoronavirusCoronavirus InfectionsDisease Models, AnimalHumansMiceSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusViral ProteinsViral VaccinesVirionViral ProteinsViral Vaccines

Identifiers

PMID16339739
PMCPMC1306801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.